Orgenesis Inc.

(ORGS) Trade

Symbol has changed to a new ticker symbol


By |


Orgenesis Inc is a part of the healthcare sector. It is a fully-integrated biopharmaceutical company focused on developing trans-differentiation technologies for diabetes and vertically integrating manufacturing that can optimize its abilities to scale-up its technologies for clinical trials and eventual commercialization. The company is also engaged in applying its disciplined execution to emerging technologies of other cell therapy markets in such areas as cell-based cancer immunotherapies and neurodegenerative diseases.

Contact Information

Main Phone: +1 480 659-1020
Address: 20271 Goldenrod Lane
State: MD
City / Town: Germantown
Country: USA
Postal Code: 20876

Issuer Information

Exchange: NSC
CEO: Vered Caplan
Employees: 103
NAICS: Pharmaceutical Preparation Manufacturing(325412)
$ 4.76 $ -0.04 (-0.83%)
Last Price 4.76 Change $ -0.04 Change % -0.83 Tick N/A
Bid 4.10 Bid Size 5,000.00 Ask 6.00 Ask Size 600.00
Open 4.75 High 5.11 Low 4.75 Prev Close 4.80
Last Trade Volume 41,734 52 Wk Hi 16.80 52 Wk Low 4.11
Market Cap 74.1 mi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 15,570,973.00 EPS (TTM) 0.00 PE Ratio N/A Exchange NCM